Back to Search
J. ALEXANDER BODKIN, M.D.
M.D.
Psychiatry Physician
NPI: 1235222969Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
56622(MA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
A systematic review of augmentation strategies for patients with major depressive disorder.
PMID 19752841·Psychopharmacol Bull·2009
1-meta
Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.
PMID 19565524·Hum Psychopharmacol·2009
6-review
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.
PMID 18629432·J Neural Transm (Vienna)·2008
8-other
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.
PMID 18312042·J Clin Psychiatry·2008
4-observational
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.
PMID 17196056·J Clin Psychiatry·2006
8-other
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
PMID 16390892·Am J Psychiatry·2006
4-observational
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
PMID 16390886·Am J Psychiatry·2006
3-trial
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
PMID 15669893·J Clin Psychiatry·2005
3-trial
A three-factor analytic model of the MADRS in geriatric depression.
PMID 12497559·Int J Geriatr Psychiatry·2003
8-other
Executive dysfunction predicts nonresponse to fluoxetine in major depression.
PMID 10940443·J Affect Disord·2000
3-trial
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
PMID 15677608·Am J Psychiatry·2005
3-trial
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.
PMID 12411221·Am J Psychiatry·2002
3-trial
A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
PMID 19142122·J Clin Psychopharmacol·2009
4-observational
Hydrogen peroxide is a novel mediator of inflammatory hyperalgesia, acting via transient receptor potential vanilloid 1-dependent and independent mechanisms.
PMID 19059721·Pain·2009
7-preclinical
The Sharpless asymmetric aminohydroxylation reaction: optimising ligand/substrate control of regioselectivity for the synthesis of 3- and 4-aminosugars.
PMID 18600276·Org Biomol Chem·2008
8-other
Modelling Staphylococcus aureus-induced septicemia using NMR.
PMID 17899589·Magn Reson Med·2007
8-other
Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy.
PMID 17785514·Antimicrob Agents Chemother·2007
8-other
Incorporating diverse data and realistic complexity into demographic estimation procedures for sea otters.
PMID 17205905·Ecol Appl·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 115 MILL STREET
BELMONT, MA 02478 - Phone
- (617) 855-3186
Quick Facts
- NPI
- 1235222969
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile